{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:41:50Z","timestamp":1792489310730,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25293176"],"award-info":[{"award-number":["25293176"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H24-Bsou-kanen-ippan-013"],"award-info":[{"award-number":["H24-Bsou-kanen-ippan-013"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jhep.2015.03.020","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T08:59:33Z","timestamp":1431161973000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Characterization of novel entecavir resistance mutations"],"prefix":"10.1016","volume":"63","author":[{"given":"Sanae","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Omagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Iio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Isogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunamasa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Karino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.03.020_b0005","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2007.02.040","article-title":"Navigating the maze of hepatitis B treatments","volume":"132","author":"Lok","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.03.020_b0010","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.v18.i48.7149","article-title":"Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues","volume":"18","author":"Song","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.03.020_b0015","doi-asserted-by":"crossref","first-page":"478631","DOI":"10.6064\/2012\/478631","article-title":"Direct acting antivirals for the treatment of chronic viral hepatitis","volume":"2012","author":"Karayiannis","year":"2012","journal-title":"Scientifica"},{"key":"10.1016\/j.jhep.2015.03.020_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8C","author":"Men\u00e9ndez-Arias","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhep.2015.03.020_b0025","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside na\u00efve patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.020_b0030","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-na\u00efve patients is rare through 5 years of therapy","volume":"49","author":"Tenney","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.020_b0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.41.7.1444","article-title":"Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus","volume":"41","author":"Innaimo","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0040","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/AAC.42.12.3200","article-title":"In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir","volume":"42","author":"Seifer","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0045","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/AAC.01061-09","article-title":"Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation","volume":"54","author":"Mukaide","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0050","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20365","article-title":"A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D","volume":"40","author":"Tanaka","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.020_b0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21345","article-title":"Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens","volume":"44","author":"Sugiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.020_b0065","doi-asserted-by":"crossref","first-page":"21713","DOI":"10.1074\/jbc.M501564200","article-title":"Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain","volume":"280","author":"Kimura","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.03.020_b0070","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1099\/0022-1317-82-4-883","article-title":"A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness","volume":"82","author":"Sugauchi","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2015.03.020_b0075","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2015.03.020_b0080","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1053\/j.gastro.2008.10.048","article-title":"Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes","volume":"136","author":"Sugiyama","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.03.020_b0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.03.020_b0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0097-8485(92)80010-W","article-title":"Presto(protein engineering simulator): A vectorized molecular mechanics program for biopolymers","volume":"16","author":"Morikami","year":"1992","journal-title":"Comput Chem"},{"key":"10.1016\/j.jhep.2015.03.020_b0095","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"10.1016\/j.jhep.2015.03.020_b0100","first-page":"19","article-title":"A method to enhance the hit ratio by a combination of structure-based drug screening and ligand-based screening","author":"Omagari","year":"2008","journal-title":"Adv Appl Bioinforma Chem"},{"key":"10.1016\/j.jhep.2015.03.020_b0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmgm.2005.04.004","article-title":"Similarities among receptor pockets and among compounds: analysis and application to in silico ligand screening","volume":"24","author":"Fukunishi","year":"2005","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jhep.2015.03.020_b0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jhep.2005.11.036","article-title":"Cellular and virological mechanisms of HBV drug resistance","volume":"44","author":"Locarnini","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.020_b0115","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.020_b0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2006.11.016","article-title":"Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient","volume":"46","author":"Villet","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.020_b0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2893.2010.01378.x","article-title":"Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains","volume":"18","author":"Amini-Bavil-Olyaee","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2015.03.020_b0135","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/JVI.02395-06","article-title":"Inhibition of hepatitis B virus polymerase by entecavir","volume":"81","author":"Langley","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2015.03.020_b0140","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.01440-06","article-title":"In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants","volume":"51","author":"Brunelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.03.020_b0145","doi-asserted-by":"crossref","first-page":"e9195","DOI":"10.1371\/journal.pone.0009195","article-title":"Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir","volume":"5","author":"Walsh","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.03.020_b0150","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jmv.20981","article-title":"Successful treatment of an entecavir-resistant hepatitis B virus variant","author":"Yatsuji","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.03.020_b0155","first-page":"11833","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication","volume":"77","author":"Iv","year":"2003","journal-title":"In Vitro"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T21:06:10Z","timestamp":1668632770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815002032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0168827815002032"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.03.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of novel entecavir resistance mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}